271 related articles for article (PubMed ID: 8778209)
1. B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis.
Perrin PJ; Scott D; June CH; Racke MK
Immunol Res; 1995; 14(3):189-99. PubMed ID: 8778209
[TBL] [Abstract][Full Text] [Related]
2. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
[TBL] [Abstract][Full Text] [Related]
3. Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Davis TA; Gray GS; Doggett MJ; Abe R; June CH; Racke MK
J Neuroimmunol; 1996 Mar; 65(1):31-9. PubMed ID: 8642061
[TBL] [Abstract][Full Text] [Related]
4. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
Chang TT; Kuchroo VK; Sharpe AH
Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
[No Abstract] [Full Text] [Related]
5. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
[TBL] [Abstract][Full Text] [Related]
6. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis.
Hurwitz AA; Sullivan TJ; Krummel MF; Sobel RA; Allison JP
J Neuroimmunol; 1997 Mar; 73(1-2):57-62. PubMed ID: 9058759
[TBL] [Abstract][Full Text] [Related]
7. Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis.
Perrin PJ; Lovett-Racke A; Phillips SM; Racke MK
Histol Histopathol; 1999 Oct; 14(4):1269-76. PubMed ID: 10506942
[TBL] [Abstract][Full Text] [Related]
8. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK
J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805
[TBL] [Abstract][Full Text] [Related]
9. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis in the Wistar rat: dependence of MBP-specific T cell responsiveness on B7 costimulation.
Zhou J; Zhang JS; Ma BL; Mamula MJ
Autoimmunity; 2002 May; 35(3):191-9. PubMed ID: 12389644
[TBL] [Abstract][Full Text] [Related]
11. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
[TBL] [Abstract][Full Text] [Related]
12. Costimulatory regulation of T cell function.
Chambers CA; Allison JP
Curr Opin Cell Biol; 1999 Apr; 11(2):203-10. PubMed ID: 10209159
[TBL] [Abstract][Full Text] [Related]
13. CD28-independent induction of experimental autoimmune encephalomyelitis.
Chitnis T; Najafian N; Abdallah KA; Dong V; Yagita H; Sayegh MH; Khoury SJ
J Clin Invest; 2001 Mar; 107(5):575-83. PubMed ID: 11238558
[TBL] [Abstract][Full Text] [Related]
14. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.
Racke MK; Scott DE; Quigley L; Gray GS; Abe R; June CH; Perrin PJ
J Clin Invest; 1995 Nov; 96(5):2195-203. PubMed ID: 7593605
[TBL] [Abstract][Full Text] [Related]
16. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
17. Effect of CD80 and CD86 on T cell cytokine production.
Petro TM; Chen SS; Panther RB
Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
[TBL] [Abstract][Full Text] [Related]
18. Break of neonatal Th1 tolerance and exacerbation of experimental allergic encephalomyelitis by interference with B7 costimulation.
Bell JJ; Min B; Gregg RK; Lee HH; Zaghouani H
J Immunol; 2003 Aug; 171(4):1801-8. PubMed ID: 12902480
[TBL] [Abstract][Full Text] [Related]
19. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
20. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
